A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group

Pediatric Blood &Cancer, EarlyView.


https://ift.tt/2qYV2bh